Anesthetic agents inhaled

The onset of action is fast (within 60 seconds) for the intravenous anesthetic agents and somewhat slower for inhalation and local anesthetics. The induction time for inhalation agents is a function of the equiUbrium estabUshed between the alveolar concentration relative to the inspired concentration of the gas. Onset of anesthesia can be enhanced by increasing the inspired concentration to approximately twice the desired alveolar concentration, then reducing the concentration once induction is achieved (3). The onset of local anesthetic action is influenced by the site, route, dosage (volume and concentration), and pH at the injection site. 

The total U.S. market value for the anesthetic agents Hsted was 299.9 million ia 1990 (162). General inhalation agents, valued at 154.5 million, comprised over half (51.5%) of the 1990 market. General iv anesthetics were valued at 111.5 million (37.2%). Local iajectable agents, at 33.9 million, represented the smallest portion of the market (11.3%). U.S. sales for selected anesthesia pharmaceuticals are given ia Table 6. 

The ability of the anesthetic agent to function is related to the partial pressure of the drug in the brain. Two major factors dictate the concentration of anesthetic agent in the neural tissue (1) the pressure gradients from lung alveoli to the brain (i.e., inhaled gas —> alveoli — bloodstream —> brain) and (2) the lipid solubility of the drug that enables it to pass between the blood-brain barrier to the central nervous system. 

Shulman, M., and M.S.Sadove. 1967. 1,1,1,2-Tetrafluoroethane an inhalation anesthetic agent of intermediate potency. Anaesthesia Analgesia 46 629-633. 

Uses. Blowing agent in foamed plastics in the production of tetraethyl lead formerly used as an inhalation anesthetic agent... 

Volatile anesthetic agents - Close perioperative monitoring is recommended in patients undergoing general anesthesia who are on amiodarone therapy as they may be more sensitive to the myocardial depressant and conduction effects of halogenated inhalational anesthetics. 

Propofol can be used for induction as well as maintenance of anesthesia. It is very lipophilic and induction of anesthesia takes place within 30 seconds. After a single dose the patient awakes in approximately 5 minutes and after anesthesia by continuous intravenous administration of longer duration recovery may take 10-15 minutes. It can be used in combination with the usual range of premedications, analgesics, muscle relaxants and inhalation anesthetic agents. 

A most important advantage of ketamine over other anesthetic agents is its potential for administration by the IM route. This is particularly useful in anesthetizing children, since anesthesia can be induced relatively quickly in a child who resists an inhalation induction or the insertion of an IV line. Ketamine has a limited but useful role as an IM induction agent and in pediatrics. 

Balanced Anesthesia with Inhalational Anesthetic Agents... 

A comparison of the minimum alveolar concentration (MAC) with the oil-gas partition coefficient of several inhalational anesthetic agents. 

In malignant hyperthermia (MFI), muscle rigidity and fever develop rapidly, following exposure to inhalation anesthetic agents or succinylcholine. The gene for this disorder was recently described. Other differential diagnostic considerations include ... 

Ensuring an adequate depth of anesthesia depends on achieving a therapeutic concentration of the anesthetic in the CNS. The rate at which an effective brain concentration is achieved (ie, time to induction of general anesthesia) depends on multiple pharmacokinetic factors that influence the brain uptake and tissue distribution of the anesthetic agent. The pharmacokinetic properties of the intravenous anesthetics (Table 25-1) and the physicochemical properties of the inhaled agents (Table 25-2) directly influence the pharmacodynamic effects of these drugs. These factors also influence the rate of recovery when the administration of anesthetic is discontinued. 

Depth of anesthesia is determined by the concentration of anesthetic agent that reaches the brain. Brain concentration, in turn, depends on the solubility and transport of the anesthetic agent in the bloodstream and on its partial pressure in inhaled air. Anesthetic potency is usually expressed as a minimum alveolar concentration (MAC), defined as the percent concentration of anesthetic in inhaled air that results in anesthesia in 50% of patients. As shown in Table 9.6, nitrous oxide, N2O, is the least potent of the common anesthetics. Fewer than 50% of patients are immobilized by breathing an 80 20 mix of nitrous oxide and oxygen. Methoxyflurane is the most potent agent a partial pressure of only 1.2 mm Hg is sufficient to anesthetize 50% of patients, and a partial pressure of 1.4 mm Hg will anesthetize 95%. 

Inhaled anesthetics currently in use include halo-genated volatile liquids such as desflurane, enflurane, halothane, isoflurane, methoxyflurane, and sevoflurane (Table 11-1). These volatile liquids are all chemically similar, but newer agents such as desflurane and sevoflurane are often used preferentially because they permit a more rapid onset, a faster recovery, and better control during anesthesia compared to older agents such as halothane.915 These volatile liquids likewise represent the primary form of inhaled anesthetics. The only gaseous anesthetic currently in widespread use is nitrous oxide, which is usually reserved for relatively short-term procedures (e.g., tooth extractions). Earlier inhaled anesthetics, such as ether, chloroform, and cyclopropane, are not currently used because they are explosive in nature or produce toxic effects that do not occur with the more modern anesthetic agents. 

Golembiewski J. Considerations in selecting an inhaled anesthetic agent case studies. Am J Health Syst Pharm. 2004 61(suppl 4) S10-S17. 

All of the inhalational anesthetic agents augment both the degree and duration of the neuromuscular blockade induced by the nondepolarizing muscle relaxants. 

Whatever the mechanisms responsible for bronchial hyperreactivity, bronchoconstriction itself seems to result not simply from the direct effect of the released mediators but also from their activation of neural or humoral pathways. Evidence for the importance of neural pathways stems largely from studies of laboratory animals. Thus, the bronchospasm provoked in dogs by histamine can be greatly reduced by pretreatment with an inhaled topical anesthetic agent, by transection of the vagus nerves, and by pretreatment with atropine. Studies of asthmatic humans, however, have shown that treatment with atropine causes only a reduction in—not abolition of—the... 

Inhaled gases are the mainstay of anesthesia and are primarily used for the maintenance of anesthesia after administration of an intravenous agent. Inhalation anesthetics have a benefit that is not available with intravenous agents, since the depth of anesthesia can be rapidly altered by changing the concentration of the inhaled anesthetic. Because most of these agents are rapidly eliminated from the body, they do not cause postoperative respiratory depression. 

---